Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer
- PMID: 18043603
- DOI: 10.1038/ncponc1017
Cisplatin alone or in combination versus hydroxyurea during pelvic irradiation for cervical cancer
Comment on
-
Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.J Clin Oncol. 2007 Jul 1;25(19):2804-10. doi: 10.1200/JCO.2006.09.4532. Epub 2007 May 14. J Clin Oncol. 2007. PMID: 17502627 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources